Ads
related to: Treatment Macular Degeneration and Macular Degeneration- Wet AMD FAQs
Get Answers To Frequently Asked
Questions About Wet AMD
- Clinical Study Results
See The Results of A Clinical Study
To Learn More About This Treatment
- Financial Assistance
Learn About Financial Support
That May Be Available To You
- Appointment Tips
Get Tips And Useful Information
To Talk to your Retina Specialist
- Wet AMD FAQs
Search results
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 3 days agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration
Journal of the American Medical Association· 3 days agoThis secondary analysis of the ASPREE randomized clinical trial, was conducted to evaluate the effect of long-term low-dose aspirin on age-related macular degeneration.
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 5 days agoYesafili is a trademark of Biosimilars Newco, a Biocon Biologics company. Opuviz is a trademark of...
2 Biotech Stocks to Buy in May
Motley Fool via Yahoo Finance· 7 hours agoFor reference, Dupixent's sales were $11.59 billion last year. Regeneron's second-most-important product, Eylea, is at a critical point. Eylea is a...
Ranibizumab is Safe for Treating Retinopathy of Prematurity
UB Reporter· 2 weeks agoFor several decades, laser therapy has been the primary treatment method for ROP. Laser treatment involves burning the infant’s peripheral retina to stop ...
Foundation Fighting Blindness to Host VISIONS 2024 Conference
WKBN 27 Youngstown· 1 week ago...PRNewswire/ -- The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host its VISIONS 2024 conference at the Chicago Marriott Downtown...diseases such as retinitis pigmentosa, Usher syndrome, Stargardt disease, Leber...
Biocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Investing.com· 5 days agoBiocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Akari Therapeutics, Plc (NASDAQ:AKTX) Short Interest Up 266.7% in April
ETF DAILY NEWS· 2 weeks agoAkari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 2,200 shares, a growth ...
Daily Low-Dose Aspirin Fails to Prevent AMD in Older Adults
MedPage Today· 3 days agoUse of daily low-dose aspirin for 3 years didn't prevent age-related macular degeneration (AMD) in...
6 Everyday Habits That You Didn't Know Are Ruining Your Vision
CNET· 4 days agoIf you've never experienced any issues with your vision or your eye health for that matter, then you...
Ad
related to: Treatment Macular Degeneration and Macular Degeneration